Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Frataxin is a highly conserved mitochondrial protein essential for iron-sulfur cluster assembly and iron homeostasis. Deficiency leads to Friedreich's ataxia, a neurodegenerative disorder. It is primarily involved in the assembly of iron-sulfur clusters, acts as an iron chaperone, and protects against oxidative damage.
Frataxin stimulates Fe–S cluster biosynthesis by accelerating persulfide transfer. It is also involved in cellular iron homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Frataxin.